🇺🇸 FDA
Pipeline program

clinical trial to determine the feasibility and safety of the mesenchymal stem cells use in women over 50 years of age with urinary incontinencee

SUITH

Phase 1 other active

Quick answer

clinical trial to determine the feasibility and safety of the mesenchymal stem cells use in women over 50 years of age with urinary incontinencee for Stress or mixed urinary incontinence in women over 50 years of age not responding to conventional treatments is a Phase 1 program (other) at The George Institute with 1 ClinicalTrials.gov record(s).

Program details

Company
The George Institute
Indication
Stress or mixed urinary incontinence in women over 50 years of age not responding to conventional treatments
Phase
Phase 1
Modality
other
Status
active

Clinical trials